Program: Saturday (03.11.2007)

14:00 – 15:30

Room: Pipin II
(Dorint Hotel)

Workshop Cancer Survivorship

  • Sandra Horning
  • Flora van Leeuwen
  • Myocardial Infarction Mortality Risk after Treatment for HL: a Collaborative British Cohort Study

    • Anthony Swerdlow
  • Risk Factors for Cardiovascular Disease; Dutch Results

    • Berthe Aleman
  • Clinical Applications of Modelled Second Cancer Risk Among HL Survivors

    • David Hodgson
  • Breast Tumors Induced by High-dose Radiation Display Similar Genetic Profiles

    • Annegien Broeks
  • Screening for Lung Cancer in Patients at High Risk of this Second Cancer after Treatment for HL

    • John Radford
  • Breast Cancer Screening with MRI in Female HL Survivors

    • Andrea Ng

14:00 – 15:30

Room: Pipin I
(Dorint Hotel)

Workshop Pathology

  • Randy Gascoyne
  • Harald Stein
  • Cytokine Gene Expression and T-Cell Transcription Factor Profile of the T-Cells of the Nodular Lymphocyte Predominance Type of HL

    • Cigdem Atayar
  • Double-Positive CD4+CD8+ T-Cell Populations in Nodular Lymphocyte Predominant HL: Further Characterization and Relationship to Other Entities

    • Aliyah Rahemtullah
  • CD4/CD8-double Positive T-Cells in Nodular Lymphocyte Predominance HL

    • Randy Gascoyne
  • Regulatory T-Cells in Classical HL

    • Ramon Bosch
  • Biologic Prognostic Markers in cHL: Evaluation of Characteristics of RS Cells as well as the Tumor Infiltrating Lymphocytes

    • Eric Hsi
  • dentification and Purification of Hodgkin Cells from Lymph Nodes Involved by Classical HL by Flow Cytometry and Flow Cytometric Cell Sorting

    • Jonathan Fromm

14:00 – 15:30

Room: Martin & Augustin
(Dorint Hotel)

Workshop Allogeneic Stem Cell Transplantation

  • James Armitage
  • Norbert Schmitz
  • Allogeneic Hematopoietic Cell Transplantation for HL

    • Ginna Laport
  • Allogeneic Stem Cell Transplantation (Allo-SCT) in HL: The European Point of View

    • Anna Sureda
  • Improved Outcome Following Reduced Intensity Allogeneic Transplantation in HL Relapsing Post-Autologous Transplantation

    • Stephen Mackinnon
  • Allogeneic/Syngeneic/Autologous Transplantation – a Comparison

    • Philip Bierman

14:00 – 15:30

Room: Severin
(Dorint Hotel)

Workshop Pædiatric Hodgkin Lymphoma

  • Dieter Körholz
  • Judith Landman-Parker
  • Current Protocols and Concepts in the USA

    • Cindy L. Schwartz
  • Strategy of the EuroNet-PHL-C1 Protocol for the Treatment of Classical HL in Children and Adolescents

    • Dieter Körholz
  • First International Inter-Group Study for Lymphocyte Predominant HL in Children and Adolescents

    • Judith Landman-Parker
  • Current Children’s Oncology Group (COG) Protocol for LPHL

    • Burton Appel

16:00 – 17:30

Room: Pipin II
(Dorint Hotel)

Workshop Future Studies / Intergroup Trials

  • Richard Fisher
  • John Raemaekers
  • The new trial generation of the German Hodgkin Study Group (GHSG)

    • Andreas Engert
  • The H10 EORTC/GELA Randomized Intergroup Trial on Early FDG-PET Scan Guided Treatment Adaptation Versus Standard Combined Modality Treatment in Patients with Supradiaphragmatic Stage I/II HL

    • Marc André
  • Response-Adapted Therapy Using FDG-PET Scanning after Initial ABVD: The UK NCRI, Italian and Nordic Trial in Advanced HL

    • Peter Johnson
  • Identification of Relevant and Practical Questions for an Transatlantic Intergroup Designs

    • Oliver Press
  • Development of ABVD as Standard Treatment for HL

    • Bruce Cheson
  • Organisation Central On-line PET Review

    • Sigrid Stroobants

16:00 – 18:00

Room: Isabellensaal

Scientific Session Chronic Inflammation

  • Bernd Dörken
  • Sibrand Poppema
  • RNA Expression Analyses of whole Tissue Sections

    • Juan Fernando Garcia Garcia
  • The Role of Inflammatory Bystander Cells in HL

    • Gunilla Enblad
  • Gene Expression Profiling in HL: the RS Cells or the Microenvironment?

    • Christian Steidl
  • Elevated levels of HLA-B associated transcript 3 (BAT3) in sera from Hodgkin Lymphoma patients

    • Elke Pogge von Strandmann
  • T-Cells in HL

    • Sibrand Poppema
  • Autoimmunity and HL

    • Ola Landgren
  • The EBV-encoded EBNA1 in HL Cells Mediates Upregulation of the Chemokine CCL20 and the Migration of Regulatory T-Cells

    • Karl R. N. Baumforth
  • Aberrant Notch1 Activity Contributes to Plasticity of HRS Cells

    • Franziska Jundt


You a viewing the program of a past symposium. Click here to get back to the current conference.